EpiThany Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

EpiThany General Information

Description

Developer of an anti-cancer immunotherapy treatment intended to treat patients with solid tumors. The company's immunotherapy focuses on developing tumor vaccines that drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) responses, enabling physicians to target myriad tumor antigens across a spectrum of cancers, yielding a deep pipeline of Th1-selective anti-cancer vaccines.

Contact Information

Website
www.epithany.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3240 Fuhrman Avenue East
  • Suite 106
  • Seattle, WA 98102
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3240 Fuhrman Avenue East
  • Suite 106
  • Seattle, WA 98102
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiThany Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Generating Revenue
1. Early Stage VC 01-Nov-2019 Completed Clinical Trials - Phase 1
To view EpiThany’s complete valuation and funding history, request access »

EpiThany Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an anti-cancer immunotherapy treatment intended to treat patients with solid tumors. The company's immunoth
Drug Discovery
Seattle, WA

Rockville, MD
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiThany Competitors (3)

One of EpiThany’s 3 competitors is Immunomic Therapeutics, a Venture Capital-Backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunomic Therapeutics Venture Capital-Backed Rockville, MD
Gritstone bio Formerly VC-backed Emeryville, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 3 of 3 competitors. Get the full list »

EpiThany Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
UW CoMotion Accelerator/Incubator
To view EpiThany’s complete investors history, request access »

Ready to get started?

Request a free trial

EpiThany FAQs

  • When was EpiThany founded?

    EpiThany was founded in 2014.

  • Where is EpiThany headquartered?

    EpiThany is headquartered in Seattle, WA.

  • What industry is EpiThany in?

    EpiThany’s primary industry is Drug Discovery.

  • Is EpiThany a private or public company?

    EpiThany is a Private company.

  • What is EpiThany’s current revenue?

    The current revenue for EpiThany is .

  • Who are EpiThany’s investors?

    UW CoMotion has invested in EpiThany.

  • Who are EpiThany’s competitors?

    Immunomic Therapeutics, Gritstone bio, and Inovio Pharmaceuticals are competitors of EpiThany.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »